FealtySign in
Promise-keeping streak6 kept in a rowguidance & buyback

Xylem Inc.

(XYL)

CIK 1524472 · SEC filings only

Not gradedDividend record
shown as history
company entity
49 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

49 declarations · 14 raised · 34 held · 0 cut · held 48 quarters

  1. HELD$0.4300/shperiod ended 2026-06-30Filing ↗
  2. RAISED$0.4300/shperiod ended 2026-03-31Filing ↗
  3. HELD$0.4000/shperiod ended 2025-09-30Filing ↗
  4. HELD$0.4000/shperiod ended 2025-06-30Filing ↗
  5. RAISED$0.4000/shperiod ended 2025-03-31Filing ↗
  6. HELD$0.3600/shperiod ended 2024-09-30Filing ↗
  7. HELD$0.3600/shperiod ended 2024-06-30Filing ↗
  8. HELD$0.3600/shperiod ended 2024-03-31Filing ↗
  9. RAISED$0.3600/shperiod ended 2023-12-31Filing ↗
  10. HELD$0.3300/shperiod ended 2023-09-30Filing ↗
  11. HELD$0.3300/shperiod ended 2023-06-30Filing ↗
  12. HELD$0.3300/shperiod ended 2023-03-31Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
A+Guidance record
grade
company entity
6 resolved promises

Sector median (Technology): A+ across 41 graded companies

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

7 of 13 guidance figures that were graded or dropped for basis could not be graded on the same basis (54%). Guidance marked “not judged” is in neither number.

Guidance typeSaidGradedDroppedOther
Revenue · non-GAAPcannot be graded7025
Revenue · basis not stated246018
EPS · non-GAAPcannot be graded230518

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (33)

We show what was said — with its source filing — but never score it. The line under each statement says why.

  1. eps guidance fy · Jul 28, 2026
    This results in full-year adjusted earnings per share of $5.55 to $5.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · Apr 28, 2026
    This results in full-year adjusted earnings per share of $5.35 to $5.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Feb 10, 2026
    adjusted earnings per share of $5.35 to $5.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Oct 28, 2025
    This results in full-year adjusted earnings per share of $5.03 to $5.08
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Jul 31, 2025
    This results in full-year adjusted earnings per share of $4.70 to $4.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Apr 29, 2025
    This results in full-year adjusted earnings per share of $4.50 to $4.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Feb 4, 2025
    2025 full-year adjusted earnings per share guidance range of $4.50 to $4.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Oct 31, 2024
    This results in adjusted earnings per share of $4.22 to $4.24
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance fy · Jul 30, 2024
    This results in adjusted earnings per share of $4.18 to $4.28
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · May 2, 2024
    This results in adjusted earnings per share of $4.10 to $4.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · Feb 6, 2024
    adjusted earnings per share range of $4.00 to $4.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Oct 31, 2023
    This results in adjusted earnings per share of $3.71 to $3.73
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Aug 2, 2023
    This results in adjusted earnings per share of $3.50 to $3.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · May 4, 2023
    This results in adjusted earnings per share of $3.15 to $3.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Feb 7, 2023
    This results in adjusted earnings per share of $3.00 to $3.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. revenue guidance fy · Nov 1, 2022
    Xylem now expects full-year 2022 organic revenue growth to be in the range of 9 to 10 percent
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  17. eps guidance fy · Nov 1, 2022
    This results in adjusted earnings per share of $2.65 to $2.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Aug 2, 2022
    This results in adjusted earnings per share of $2.50 to $2.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. revenue guidance fy · Aug 2, 2022
    Xylem now expects full-year 2022 organic revenue growth to be in the range of 8 to 10 percent
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. revenue guidance fy · May 4, 2022
    Xylem now expects full-year 2022 organic revenue growth to be in the range of 4 to 6 percent
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · May 4, 2022
    This results in adjusted earnings per share of $2.40 to $2.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Feb 3, 2022
    This results in adjusted earnings per share of $2.35 to $2.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. revenue guidance fy · Nov 2, 2021
    Xylem now expects full-year organic revenue growth to be in the range of 3 to 4 percent
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Nov 2, 2021
    Full-year adjusted earnings per share is now expected to be in the range of $2.40 to $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance fy · Aug 3, 2021
    Full-year adjusted earnings per share is now expected to be in the range of $2.55 to $2.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. revenue guidance fy · Aug 3, 2021
    Xylem now expects full-year organic revenue growth to be in the range of 6 to 8 percent
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. revenue guidance fy · Aug 3, 2021
    9 to 11 percent on a reported basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. revenue guidance fy · May 4, 2021
    8 to 10 percent on a reported basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · May 4, 2021
    Full-year adjusted earnings per share is now expected to be in the range of $2.50 to $2.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. revenue guidance fy · May 4, 2021
    Xylem now expects full year organic revenue growth to be in the range of 5 to 7 percent
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance fy · Feb 4, 2021
    This results in adjusted earnings per share of $2.35 to $2.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. revenue guidance q · Oct 29, 2020
    Xylem expects fourth quarter organic revenue declines in the range of 6 to 8 percent
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  33. revenue guidance q · Jul 30, 2020
    expectation that organic revenue will be down in the range of 8 to 12 percent
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗

Open promises (1) · 14 superseded

Open · revenue guidance fy

Xylem now forecasts full-year 2026 revenue of approximately $9.2 billion

resolves in ~153 daysreceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem now expects full-year 2023 revenue of approximately $7.2 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem forecasts full-year 2022 revenue in the range of $5.25 to $5.35 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem now expects full-year 2024 revenue of approximately $8.5 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem forecasts full-year 2025 revenue of approximately $8. 6 to $8. 7 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem forecasts full-year 2024 revenue of approximately $8.4 to $8.5 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem now forecasts full-year 2026 revenue of approximately $9.2 to $9.3 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem forecasts full-year 2025 revenue of approximately $8. 7 to $8. 8 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem forecasts full-year 2023 revenue in the range of $5.70 to $5.80 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem now expects full-year 2024 revenue of $8.55 billion

revised by a later guidance$8.5500receipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem forecasts full-year 2026 revenue of approximately $9.1 to $9.2 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem now forecasts full-year 2025 revenue of approximately $8. 9 to $9.0 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

and 3 to 5 percent on a reported basis

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

up approximately 15 to 16 percent on a reported basis

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Xylem now expects full-year 2023 revenue growth of 8 to 9 percent on an organic and reported basis.

revised by a later guidancereceipt (opens in a new tab)

Credibility timeline

WITHDRAWN · Jul 30, 2020ABOVE · Oct 29, 2020IN LINE · Feb 25, 2022ABOVE · Feb 24, 2023IN LINE · Feb 28, 2024IN LINE · Mar 3, 2025IN LINE · Feb 25, 2026
20202026
Timeline as a list
  • Jul 30, 2020WITHDRAWNXylem withdrew 2020 guidance earlier this year
  • Oct 29, 2020ABOVEdown 10 to 14 percent on a reported basis
  • Feb 25, 2022IN LINEXylem forecasts full-year 2021 revenue in the range of $5.16 to $5.26 billion
  • Feb 24, 2023ABOVEapproximately 4 percent on a reported basis
  • Feb 28, 2024IN LINEXylem now expects full-year 2023 revenue of approximately $7.3 billion
  • Mar 3, 2025IN LINEXylem expects full-year 2024 revenue of $8.5 billion
  • Feb 25, 2026IN LINEXylem now forecasts full-year 2025 revenue of approximately $9.0 billion
6 resolved guidance promises · 33 not graded (no comparable reported figure) · resolver resolver-v5 · score score-v1. Every verdict links to its source filing. Full methodology →